|
|
||||||||
AJP - Heart and Circulatory Physiology, Vol 256, Issue 3 890-H897, Copyright © 1989 by American Physiological Society
ARTICLES |
P. V. Hautamaa, X. Z. Dai, D. C. Homans and R. J. Bache
Department of Medicine, University of Minnesota, Minneapolis 55455.
This study examined the ability of moderately well-developed coronary collateral vasculature to undergo vasoconstriction in response to alpha-adrenergic agonists, vasopressin and angiotensin, and vasodilation in response to nitroglycerin. Studies were performed in 20 dogs 4-16 wk after left anterior descending coronary artery occlusion had been produced by an Ameroid constrictor or hollow intravascular plug. Collateral flow was estimated from retrograde flow from the cannulated left anterior descending artery. Tissue flow was measured with microspheres. Agonists were introduced into the left main coronary artery to reach collaterals arising from the left circumflex and septal arteries. Vasopressin and angiotensin II decreased retrograde flow from 22.7 +/- 5.5 to 15.5 +/- 2.7 and from 19.2 +/- 2.8 to 14.3 +/- 1.9 ml/min, respectively (each P less than 0.05). Both agents also significantly decreased tissue flow to normally perfused and collateral dependent myocardium. Neither the selective alpha 1-adrenergic agonist phenylephrine nor the alpha 2-agonist B-HT 933 decreased retrograde flow. Nitroglycerin increased retrograde flow by 63 +/- 27% (P less than 0.01). Thus, although the moderately well-developed coronary collateral circulation is capable of vasoconstriction in response to vasopressin and angiotensin II, these data fail to support a role for alpha-adrenergic mechanisms in modulating collateral flow.
This article has been cited by other articles:
![]() |
D. J. Duncker and R. J. Bache Regulation of Coronary Blood Flow During Exercise Physiol Rev, July 1, 2008; 88(3): 1009 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Kersten, W. G. Toller, J. P. Tessmer, P. S. Pagel, and D. C. Warltier Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2097 - H2104. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Klassen, J. H. Traverse, and R. J. Bache Nitroglycerin dilates coronary collateral vessels during exercise after blockade of endogenous NO production Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H918 - H923. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rapps, P. R. Myers, Q. Zhong, and J. L. Parker Development of Endothelium-Dependent Relaxation in Canine Coronary Collateral Arteries Circulation, October 20, 1998; 98(16): 1675 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rapps, A. W. Jones, M. Sturek, L. Magliola, and J. L. Parker Mechanisms of Altered Contractile Responses to Vasopressin and Endothelin in Canine Coronary Collateral Arteries Circulation, January 7, 1997; 95(1): 231 - 239. [Abstract] [Full Text] |
||||
![]() |
J. H. Traverse, D. Judd, and R. J. Bache Dose-Dependent Effect of Endothelin-1 on Blood Flow to Normal and Collateral-Dependent Myocardium Circulation, February 1, 1996; 93(3): 558 - 566. [Abstract] [Full Text] |
||||
![]() |
J. H. Traverse, J. D. Altman, J. Kinn, D. J. Duncker, and R. J. Bache Effect of ß-Adrenergic Receptor Blockade on Blood Flow to Collateral-Dependent Myocardium During Exercise Circulation, March 1, 1995; 91(5): 1560 - 1567. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |